Green Bioactives, an Edinburgh, Scotland, UK-based company dedicated to the commercialization of plant vascular stem cells, raised £2.6M in Seed funding.
The round was led by Eos Advisory LLP, with participation from Regenerate Ventures’ Agtech Fund, Milltrust International Group, and Scottish Enterprise. Andrew Durkie, Partner at Eos, will join the Green Bioactives Board of Directors.
The company intends to use the funds to grow its management, production and research team capabilities, to demonstrate its biomanufacturing approach at larger scale.
Led by CEO David McElroy, Green Bioactives leverages plant vascular stem cells to create a platform for the sustainable biomanufacturing of plant biomolecules for commercial applications in the cosmetics, pharma, food and agricultural industries. The system provides improved and sustainable access to the huge, diverse, and valuable library of bioactive generated by the world’s plant population. The company’s capabilities span initial isolation of the bioactive producing plant cells through to the supply of the final purified product. GBL’s knowledge of plant vascular stem cells also provides the opportunity for the company to develop novel approaches that address the global need for sustainable.
GBL is currently working with several world-leading partners to produce high value bioactives that cannot be readily produced sustainably or economically using alternative production approaches. These include:
- A multinational consumer goods company developing and selling products in foods and drinks, home care, personal care and cosmetics
- A multinational biotechnology company developing and selling products for commercial applications in pharmaceuticals, consumer healthcare and agriculture
- A global agricultural solutions company specialising in the development, marketing, and processing of agricultural inputs such as crop protection products, seeds, and fertilizers.
GBL was founded in 2020 and is currently based at the Roslin Innovation Centre, Edinburgh, Scotland, UK.
FinSMEs
13/12/2022